Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Poultry Diagnostics Market Size & Growth Forecast 2027–2036, By Segments (Test, Product, Test Category Size, Disease, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 13815| Published Date: Jun-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Poultry Diagnostics Market size stood at USD 986.1 million in 2026 and is predicted to grow at a 9.31% CAGR from 2027 to 2036, surpassing USD 2.4 billion by 2036. The industry revenue for 2027 is estimated at USD 1.06 billion.

Base Year Value (2026)
USD 986.1 million
CAGR (2027-2036)
9.31%
Forecast Year Value (2036)
USD 2.4 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
SNAPSHOT

Poultry Diagnostics Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads the poultry diagnostics market supported by established poultry industry routine disease surveillance laboratory testing and on farm monitoring ensuring biosecurity and production consistency
  • Asia Pacific is projected at 11.19% CAGR driven by rising poultry production dense farming networks and growing adoption of diagnostics to control infectious diseases and reduce mortality

Segment Momentum

  • ELISA holds a 59.22% share due to its suitability for high-volume flock screening, offering reliable, cost-efficient, and standardized workflows for continuous poultry health monitoring across large populations.
  • Equipment & Instruments are the fastest-growing segment as diagnostic labs upgrade infrastructure to improve testing speed, throughput, and compatibility with advanced methods like PCR-based and high-precision workflows.

Market Expansion Drivers

  • Rising avian influenza and Newcastle disease outbreaks increasing routine flock disease surveillance demand.
  • Advancements in ELISA, PCR, and point-of-care diagnostics improving poultry disease detection efficiency.
  • Expanding commercial poultry farming operations driving preventive health monitoring and biosecurity investments.

Leading Market Participants

  • Top players in the poultry diagnostics market include IDEXX Laboratories, Inc. (United States), Zoetis Inc. (United States), Thermo Fisher Scientific Inc. (United States), FUJIFILM Holdings Corporation (Japan), Innovative Diagnostics SAS (France), Agrolabo S.p.A. (Italy), QIAGEN N.V. (Netherlands), BioChek B.V. (Netherlands), Bio-Rad Laboratories, Inc. (United States), Indical Bioscience GmbH (Germany).

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 986.1 million
  • 2027 Estimated Market Size: USD 1.06 billion.
  • Projected Market Size: USD 2.4 billion by 2036
  • Growth Forecast: 9.31% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: ELISA (Test) | Consumables, Reagents & Kits (Product) | Clinical Chemistry (Test Category Size) | Avian Influenza (Disease) | Reference Laboratories (End Use)
  • Emerging Opportunity Segment: PCR (Test) | Equipment & Instruments (Product) | Parasitology (Test Category Size) | Chicken Anemia (Disease) | Veterinary Hospitals & Clinics (End Use)
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising avian influenza and Newcastle disease outbreaks increasing routine flock disease surveillance demand

The recurrence of avian influenza, newcastle disease, and other infectious threats is increasing the need for timely identification of disease within commercial and managed poultry populations. In the poultry diagnostics market, heightened concerns about flock mortality, production disruptions, and disease transmission are encouraging producers and veterinary professionals to strengthen routine surveillance and testing practices. Regular diagnostic screening can support earlier identification of suspected infections, enabling more informed isolation, treatment, vaccination, and biosecurity decisions while helping poultry operations monitor disease risks across different production environments.

Advancements in ELISA, PCR, and point-of-care diagnostics improving poultry disease detection efficiency

Technological progress in laboratory and rapid diagnostic methods is improving the speed, sensitivity, and practicality of identifying poultry diseases. The poultry diagnostics market is gaining from broader use of ELISA and PCR-based techniques, alongside point-of-care solutions that can facilitate testing closer to production sites. Improved diagnostic workflows can reduce dependence on lengthy testing processes and provide veterinarians and producers with more actionable information for flock management, while advances in assay performance and testing convenience support wider adoption across commercial poultry operations with diverse surveillance requirements.

Expanding commercial poultry farming operations driving preventive health monitoring and biosecurity investments

The expansion of commercial poultry production is increasing the scale and complexity of flock health management, making systematic disease prevention increasingly important for producers. As larger operations manage substantial bird populations across intensive production environments, the poultry diagnostics market is supported by greater demand for regular health assessments, pathogen screening, and surveillance programs that complement broader biosecurity measures. Diagnostic testing can help producers identify potential health threats before they develop into larger production problems, encouraging greater integration of testing into routine veterinary management and preventive flock health protocols.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising avian influenza and Newcastle disease outbreaks increasing routine flock disease surveillance demand 2.00% High North America, Asia Pacific High Near Term
Advancements in ELISA, PCR, and point-of-care diagnostics improving poultry disease detection efficiency 1.80% Moderate Europe, Asia Pacific High Mid Term
Expanding commercial poultry farming operations driving preventive health monitoring and biosecurity investments 1.40% Moderate Latin America, Middle East & Africa Emerging Long Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
XX% Market Share in 2026

North America (Largest Region)

North America dominated the poultry diagnostics market in 2026, supported by advanced veterinary healthcare infrastructure, intensive poultry production systems, and strong emphasis on disease prevention and flock health management. Large-scale commercial poultry operations increasingly rely on diagnostic testing to identify infectious diseases, monitor herd health, and reduce production losses, creating sustained demand for molecular, immunological, and other rapid diagnostic technologies. Well-established veterinary laboratories and biosecurity practices further support adoption, while increasing attention to food safety and disease surveillance encourages producers to strengthen diagnostic capabilities throughout poultry production chains.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region as poultry production expands and producers place greater emphasis on improving productivity, biosecurity, and disease management. Rising demand for poultry meat and eggs is encouraging the modernization of commercial farming operations, while the intensification of production increases the need for early disease detection and effective monitoring. Improvements in veterinary infrastructure and growing access to diagnostic technologies are supporting adoption across developing markets. Government initiatives focused on animal health, food safety, and prevention of infectious poultry diseases are also strengthening the regional market environment.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Biosecurity Testing Focus

Germany emphasizes preventive disease monitoring and laboratory-based diagnostics to protect high-value poultry operations. German producers are increasing the use of advanced testing platforms that support early detection of avian diseases and reinforce stringent animal health standards.

France 🇫🇷

Veterinary Surveillance Support

France relies on comprehensive veterinary surveillance programs to safeguard poultry production and export requirements. French producers are increasingly integrating diagnostic testing into routine flock management to improve disease traceability and support preventive intervention strategies.

Italy 🇮🇹

Farm Health Assurance

Italy's poultry diagnostics market is centered on maintaining flock health and minimizing production losses in intensive farming systems. Producers in Italy are adopting diagnostic tools that enable earlier disease identification and facilitate more targeted veterinary management practices.

Japan 🇯🇵

Precision Health Monitoring

Japan prioritizes highly reliable diagnostic solutions that minimize production disruptions and support food safety objectives. Poultry operators in Japan are adopting sensitive testing technologies and structured surveillance programs to maintain disease-free production environments.

South Korea 🇰🇷

Rapid Outbreak Preparedness

South Korea maintains strong focus on rapid poultry disease detection due to recurring concerns over avian disease outbreaks. Diagnostic providers in South Korea are seeing demand for faster testing methods that can support timely containment measures and strengthen farm-level monitoring.

United States 🇺🇸

Integrated Disease Surveillance

The U.S. poultry diagnostics market is driven by large-scale commercial production and the need for rapid disease detection across integrated supply chains. Producers in the U.S. are expanding routine screening programs and investing in molecular diagnostics to support flock health management and biosecurity compliance.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Poultry Diagnostics Market Share (%), by Test, 2026

ELISA
PCR
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Test Segment Analysis: ELISA (Largest Segment) vs PCR (Fastest-Growing Segment)

ELISA accounted for a 59.22% share of the poultry diagnostics market in 2026, supported by its established application in detecting infectious diseases and monitoring poultry health. The technique offers practical advantages for screening and antibody-based detection, making it useful for routine diagnostic programs across poultry operations. Increasing emphasis on disease surveillance, flock health management, and early identification of infections continues to sustain demand for ELISA-based testing.

PCR is emerging as the fastest-growing testing segment as poultry producers and diagnostic laboratories increasingly prioritize rapid and highly specific identification of pathogens. Molecular testing can detect targeted genetic material and support the diagnosis of infections where early and precise identification is important for disease-control decisions. Rising concerns over infectious disease outbreaks and the need for faster diagnostic turnaround are encouraging broader adoption of PCR-based testing.

Product Segment Analysis: Consumables, Reagents & Kits (Largest Segment) vs Equipment & Instruments (Fastest-Growing Segment)

Consumables, reagents & kits held a 55.23% share of the poultry diagnostics market in 2026, reflecting their recurring role in laboratory testing and disease-screening workflows. Diagnostic assays depend on reagents, sample-processing materials, and testing kits to identify pathogens and monitor poultry health, creating sustained demand as diagnostic activity increases. Greater emphasis on routine surveillance and preventive flock management is supporting continued use of these essential testing supplies.

Equipment & instruments are expanding more rapidly as diagnostic operations adopt increasingly sophisticated technologies for molecular testing, automated analysis, and higher-throughput workflows. Modern diagnostic laboratories require reliable instruments to improve testing efficiency, accuracy, and consistency as disease surveillance becomes more technically demanding. The growing adoption of advanced diagnostic methodologies and investment in laboratory capabilities are strengthening demand for specialized equipment and instrumentation.

Segment Sub-Segment Largest Segment Fastest Growing
Test ELISA, PCR, Others ELISA PCR
Product Consumables, Reagents & Kits, Equipment & Instruments Consumables, Reagents & Kits Equipment & Instruments
Test Category Size Clinical Chemistry, Hematology, Microbiology, Parasitology, Others Clinical Chemistry Parasitology
Disease Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, Infectious Bursal Disease, Avian Pasteurellosis, Avian Encephalomyelitis, Avian Reovirus, Chicken Anemia, Others Avian Influenza Chicken Anemia
End Use Veterinary Hospitals & Clinics, Reference Laboratories, Others Reference Laboratories Veterinary Hospitals & Clinics
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the poultry diagnostics market:

1. IDEXX Laboratories Inc. (United States)

2. Zoetis Inc. (United States)

3. Thermo Fisher Scientific Inc. (United States)

4. FUJIFILM Holdings Corporation (Japan)

5. Innovative Diagnostics SAS (France)

6. Agrolabo S.p.A. (Italy)

7. QIAGEN N.V. (Netherlands)

8. BioChek B.V. (Netherlands)

9. Bio-Rad Laboratories Inc. (United States)

10. Indical Bioscience GmbH (Germany)

Advancements in veterinary science are strengthening diagnostic accuracy and speed within the poultry diagnostics market. Innovation is focused on rapid detection methods and scalable testing solutions. Continuous improvements in laboratory workflows are enhancing disease monitoring efficiency. Collaborative research efforts are improving diagnostic reliability and field applicability.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
IDEXX Laboratories Inc. (United States)
Zoetis Inc. (United States)
Thermo Fisher Scientific Inc. (United States)
FUJIFILM Holdings Corporation (Japan)
Innovative Diagnostics SAS (France)
Agrolabo S.p.A. (Italy)
QIAGEN N.V. (Netherlands)
BioChek B.V. (Netherlands)
Bio-Rad Laboratories Inc. (United States)
Indical Bioscience GmbH (Germany).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Zoetis Nov-25 Zoetis acquired Veterinary Pathology Group (VPG), a veterinary diagnostic laboratory network operating across the UK and Ireland. The acquisition expands Zoetis' diagnostics portfolio and strengthens its laboratory capabilities to support broader animal health diagnostic services.
Zoetis Mar-25 Zoetis opened a 32,000-square-foot reference laboratory in Louisville, co-located with UPS Healthcare Labport. The facility enhances nationwide specimen logistics and diagnostic testing capacity, improving operational efficiency and laboratory service delivery for the veterinary diagnostics market.
BioChek Feb-25 BioChek launched the vetnord MS-H DIVA qPCR Kit, enabling detection of Mycoplasma synoviae field strains while differentiating them from the MS-H vaccine strain. The launch expands advanced molecular diagnostic capabilities for poultry disease management.
GD Sep-24 GD introduced updated veterinary diagnostic reagents containing inactivated H5N1 and H5N8 antigens for Hemagglutination Inhibition testing. The product enhancement supports more accurate detection of avian influenza antibodies and strengthens diagnostic capabilities for poultry disease surveillance.
Harch Tech Group Mar-24 Harch Tech Group acquired NYtor to enhance its poultry diagnostics capabilities through advanced PCR-based testing technologies. The acquisition strengthens the company's molecular diagnostics portfolio and supports improved screening for poultry health applications.
Alveo Technologies, Inc. Jan-24 Alveo Technologies partnered with Pharmsure International Ltd., Royal GD, and x-OvO to co-develop and distribute an in-situ multiplex avian influenza diagnostic panel covering Group A, H5, H7, and H9 strains. The collaboration strengthens commercialization and expands access to advanced poultry diagnostic solutions.
INDICAL BIOSCIENCE GmbH Aug-21 INDICAL BIOSCIENCE GmbH acquired Check-Points, a Dutch R&D-focused company, to broaden its poultry diagnostics portfolio and strengthen its direct-to-producer offering. The acquisition enhances the company's technology capabilities and market position in poultry diagnostics.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Poultry Diagnostics Market — Custom Segments

Segment Sub-Segment
Poultry Type Broilers, Layers, Breeders, Turkeys, Ducks & Geese
Testing Purpose Disease Diagnosis, Disease Screening & Surveillance, Health & Productivity Monitoring, Food Safety Testing
Distribution Channel Direct Sales, Veterinary Distributors, Diagnostic Laboratories & Service Providers, Online & Specialty Distributors

Poultry Diagnostics Market — Custom

Custom Chapter Custom Details
Disease Surveillance and Outbreak Response Assessment
  • Surveillance Program Evolution
  • Early Detection and Monitoring Strategies
  • Outbreak Preparedness and Response
  • Diagnostic Intelligence for Disease Control
  • Future Surveillance Priorities
Precision Poultry Health Management Assessment
  • Data-Driven Flock Health Management
  • Precision Monitoring Technologies
  • Predictive Disease Management
  • Farm Productivity Optimization
Veterinary Testing Workflow Optimization Analysis
  • Diagnostic Workflow Standardization
  • Laboratory Automation and Efficiency
  • Sample Management and Turnaround Time
  • Digital Integration Across Veterinary Diagnostics
  • Future Laboratory Transformation

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

How much revenue does the poultry diagnostics market generate?

In 2027 the market for poultry diagnostics is valued at USD 1.06 billion.

What is the projected value of the poultry diagnostics industry by 2036?

Poultry Diagnostics Market size stood at USD 986.1 million in 2026 and is predicted to grow at a 9.31% CAGR from 2027 to 2036, surpassing USD 2.4 billion by 2036.

Why is preventive disease surveillance becoming a key purchasing priority in the poultry diagnostics market?

Frequent disease outbreaks are encouraging producers to replace reactive testing with routine surveillance, increasing recurring demand for serological and molecular diagnostics that support earlier detection and reduce operational disruption.

How are advances in diagnostic technologies accelerating adoption across commercial poultry operations?

Improved ELISA, PCR, and point-of-care diagnostics deliver faster and more reliable results, enabling routine health monitoring, quicker containment decisions, and broader integration of diagnostics into everyday flock management and biosecurity programs.

Why does ELISA dominate the poultry diagnostics market?

ELISA holds a 59.22% share due to its suitability for high-volume flock screening, offering reliable, cost-efficient, and standardized workflows for continuous poultry health monitoring across large populations.

How are Equipment & Instruments driving growth in the poultry diagnostics market?

Equipment & Instruments are the fastest-growing segment as diagnostic labs upgrade infrastructure to improve testing speed, throughput, and compatibility with advanced methods like PCR-based and high-precision workflows.

Why is North America the largest market for poultry diagnostics?

North America leads the poultry diagnostics market supported by established poultry industry routine disease surveillance laboratory testing and on farm monitoring ensuring biosecurity and production consistency

What is driving Asia Pacific growth in poultry diagnostics demand?

Asia Pacific is projected at 11.19% CAGR driven by rising poultry production dense farming networks and growing adoption of diagnostics to control infectious diseases and reduce mortality

What are the prominent companies operating in the poultry diagnostics landscape?

Top players in the poultry diagnostics market include IDEXX Laboratories, Inc. (United States), Zoetis Inc. (United States), Thermo Fisher Scientific Inc. (United States), FUJIFILM Holdings Corporation (Japan), Innovative Diagnostics SAS (France), Agrolabo S.p.A. (Italy), QIAGEN N.V. (Netherlands), BioChek B.V. (Netherlands), Bio-Rad Laboratories, Inc. (United States), Indical Bioscience GmbH (Germany).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →